PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment. Traditionally, PGT-A requires an invasive biopsy of a developing embryo for the removal and testing of a few cells.
PerkinElmer’s PG-Seq Rapid Non-Invasive PGT-A kit is specifically designed for this type of sample, which enables embryos to remain fully intact. The non-invasive test leverages PerkinElmer’s biopsy-based PG-Seq kit 2.0, to test the spent embryo culture media to accurately detect aneuploidies, as well as structural rearrangements, including unbalanced translocations and segmental errors.
PerkinElmer Inc.